Apparent effect of ascorbic acid medication on semen metal levels.
The apparent effect of ascorbic acid therapy for nonspecific spermagglutination on semen levels of ascorbic acid as well as macro- and micrometals was determined in 20 men (ages 25 to 38). Pretreatment diagnosis was based on infertility and relatively low ratings in sperm density, motility, motility index, and semen volume, and were associated with large numbers of abnormal sperm, sperm precursors, and leukocytes. The pretreatment levels of ascorbic acid, sodium, iron, potassium, zinc, manganese, lead, magnesium, and copper were measured in each patient's semen and compared with levels following 60 days of dietary vitamin C supplementation (1.0 gm/day). Analysis of the vitamin C preparation prescribed revealed that each subject was given an impure ascorbic acid medication to supplement a normal diet. Therefore, the significant increases in levels of ascorbic acid and metals in semen following therapy could not be attributed to ascorbic acid alone, nor, similarly, the improved physical parameters of each subject's semen following therapy; no apparent spermagglutination and restored fertility may be due to the interaction of ascorbic acid with cations found in semen.
D000328:Adult; D001205:Ascorbic Acid / Q000494:pharmacology*; D002118:Calcium / Q000032:analysis; D003300:Copper / Q000032:analysis; D006801:Humans; D007501:Iron / Q000032:analysis; D007854:Lead / Q000032:analysis; D008274:Magnesium / Q000032:analysis; D008297:Male; D008345:Manganese / Q000032:analysis; D008670:Metals / Q000032:analysis*; D011188:Potassium / Q000032:analysis; D012661:Semen / Q000032:analysis / Q000187:drug effects*; D012964:Sodium / Q000032:analysis; D013073:Sperm Agglutination / Q000187:drug effects*; D015032:Zinc / Q000032:analysis
D008670:Metals; D007854:Lead; D008345:Manganese; D003300:Copper; D012964:Sodium; D007501:Iron; D008274:Magnesium; D015032:Zinc; D001205:Ascorbic Acid; D011188:Potassium; D002118:Calcium